Codexis
CDXS
$2.66
Share price
0.38%
Change (1 day)
-32.14%
Change (1 year)
Categories
Operating Margin for Codexis (CDXS)
Operating Margin as of April 2024 (TTM): -40.92%
According to Codexis 's latest financial reports and stock price the company's current Operating Margin is -40.92%. At the end of 2021 the company had an Operating Margin of -21.67%.
Operating Margin history for Codexis from 2009 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -21.67% | -37.45% |
| 2020 | -34.64% | 88.96% |
| 2019 | -18.33% | -1.66% |
| 2018 | -18.64% | -59.4% |
| 2017 | -45.92% | 161.85% |
| 2016 | -17.54% | -5.65% |
| 2015 | -18.59% | -65.66% |
| 2014 | -54.13% | -58.24% |
| 2013 | -129.62% | 274.18% |
| 2012 | -34.64% | 174.45% |
| 2011 | -12.62% | 94.29% |
| 2010 | -6.50% | -70.38% |
| 2009 | -21.94% | -73.91% |
| 2008 | -84.07% | -42.21% |
| 2007 | -145.47% | -2.39% |
| 2006 | -149.04% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 34.61% | -184.58% | 🇺🇸 USA |
 Merck MRK | 27.73% | -167.77% | 🇺🇸 USA |
 Dupont De Nemours DD | 11.19% | -127.35% | 🇺🇸 USA |
 Balchem BCPC | 14.19% | -134.68% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.